Essential medicines for COPD and asthma in low and middle-income countries.

نویسندگان

  • Yaser T Bazargani
  • Anthonious de Boer
  • Hubert G M Leufkens
  • Aukje K Mantel-Teeuwisse
چکیده

Access to medications for chronic disease management is limited in many low and middle-income countries (LMICs), resulting in suboptimal care and avoidable morbidity and mortality. We performed a survey of COPD and asthma medicines that appeared on the national essential medicines lists (NEMLs) of 32 LMICs. Nearly all countries (>90%) had assigned essential medicines for treatment of exacerbations and early stable disease stages, but not for steps 4 (22%) and 5 (6%) controlled asthma management. The number of treatment options was limited, with long-acting β2-agonists (LABA) and combination dosage forms being notably absent. Suboptimal availability of chronic respiratory disease medicines suggests that implementation of NEMLs is the main problem in clinical practice.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.

BACKGROUND Almost 300 million people suffer from asthma, yet many in low- and middle-income countries have difficulty accessing essential asthma medicines. Availability, price and affordability of medicines are likely to affect access. Very few studies have included asthma medicines, particularly inhaled corticosteroids, in these countries. Reflections about international reference prices (IRPs...

متن کامل

Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases

BACKGROUND WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. We undertook a secondary analysis of data from 30 surveys in low- and middle-income countries, conducted from 2008-2015 using the World Health Organization (WHO)/Health Action...

متن کامل

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies

The struggles that challenge health systems in developed countries with respect to innovative high-cost medicines are some of the challenges the Global South face when accessing essential medicines. Asthma is one such example in which access to essential medicines may not be a big problem in high-income countries but that compliance and optimal use may be similar to low-income countries, for so...

متن کامل

The Implications of Global Neurosurgery for Low- and Middle-Income Countries. The Case of Cameroon.

The unequal distribution of neurosurgical resources and diseases in the world contributes to inequality. Eight in ten neurosurgical cases needing essential neurosurgical care are found in low- and middle-income countries (LMICs); however, LMICs lack the neurosurgical resources to address these needs. Besides, where neurosurgical care is available, it is not financially accessible to the majorit...

متن کامل

Relationship between the provision of injection services in ambulatory physician offices and prescribing injectable medicines

Background: Overuse of injections is a common problem in many low-income and middle income countries. Whil

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Thorax

دوره 69 12  شماره 

صفحات  -

تاریخ انتشار 2014